Methods and compositions for producing granulosa-like cells
AssigneePresident and Fellows of Harvard College
InventorsMerrick Pierson Smela, Christian Kramme, Pranam Chatterjee, George M. Church
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions for differentiating induced pluripotent stem cells into granulosa-like cells by overexpressing transcription factors such as NR5A1 and a RUNX family protein (e.g., RUNX1 and/or RUNX2).
Claims31
-58. (canceled)
A human induced pluripotent stem cell (hiPSC) comprising:
- (i) an exogenous polynucleotide comprising an open reading frame encoding NR5A1 protein;
- and
- (ii) an exogenous polynucleotide comprising an open reading frame encoding RUNX1 protein.
A population of hiPSCs, wherein a plurality of the hiPSCs in the population comprises:
- (i) an exogenous polynucleotide comprising an open reading frame encoding NR5A1 protein;
- and
- (ii) an exogenous polynucleotide comprising an open reading frame encoding RUNX1 protein.
A method of producing a population of cells that express one or more of AMHR2, CD82, and FOXL2, and that do not express detectable levels of EPCAM, the method comprising:
- (i) transfecting one or more hiPSCs to express:
- (a) a polynucleotide comprising an open reading frame encoding NR5A1 protein having the amino acid sequence of SEQ ID NO:
- 1, and
- (b) polynucleotide comprising an open reading frame encoding RUNX1 protein having the amino acid sequence of SEQ ID NO:
- 2;
- and
- (ii) culturing the one or more cells resulting from (i) in culture media, thereby producing a population of cells that express one or more of AMHR2, CD82, and FOXL2, and that do not express detectable levels of EPCAM.
Dependencies are inferred from the claim text.